A national vaccination program to prevent swine flu will begin in three weeks, now that the Food and Drug Administration has approved four vaccines against the disease. Preliminary data indicates that one dose should be enough to provide immunity in an adult—not two, as was initially believed—easing fears that there wouldn’t be enough vaccine to cover the entire at-risk population.
Still, supplies of the vaccine will initially be tight. The U.S. has ordered 195 million doses, but the first production runs are expected to turn out about 45 million doses. Those most at risk from the disease, including children and pregnant women, will get first crack at the vaccine.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
5 immersive books to read this April for a brief escapeThe Week Recommends A dystopian tale takes us to the library, a journalist's ode to her refugee parents and more
-
'The winners and losers of AI may not be where we expect'Instant Opinion Opinion, comment and editorials of the day
-
Shingles vaccine cuts dementia risk, study findsSpeed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
